Abstract-To construct biologically interpretable features and facilitate Muscular Dystrophy (MD) sub-types classification, we propose a novel integrative scheme utilizing PPI network, functional gene sets information, and mRNA profiling. The workflow of the proposed scheme includes three major steps: First, by combining protein-protein interaction network structure and gene co-expression relationship into new distance metric, we apply affinity propagation clustering to build gene sub-networks. Secondly, we further incorporate functional gene sets knowledge to complement the physical interaction information. Finally, based on constructed subnetwork and gene set features, we apply multi-class support vector machine (MSVM) for MD sub-type classification, and highlight the biomarkers contributing to the sub-type prediction. The experimental results show that our scheme could construct sub-networks that are more relevant to MD than those constructed by conventional approach. Furthermore, our integrative strategy substantially improved the prediction accuracy, especially for those hard-to-classify sub-types.
INTRODUCTION
The Muscular Dystrophy (MD) [1] is a group of inherited muscle disease characterized by progressive muscle wasting and weakness, consisting of several sub-types with different severity. Although most of related defect genes and proteins have been identified, there still lacks effective treatment as the disease pathways are not clearly understood. The availability of advanced expression measurement provides the opportunity to elucidate disease markers involved in MD progression.
Traditional disease biomarker discovery is usually performed by individual gene based classification approaches [2] , which ignore the internal relationship among genes and face the curse-of-dimensionality problem [3] . Many computational efforts integrate biological knowledge to address those problems. For examples, several supervised approaches [4] [5] [6] identify phenotype-specific PPI subnetworks to reveal related genetic pathways or predict clinical outcomes. Functional gene set categorization was also combined with clinical information to classify disease samples [7] . However, conventional methods based on supervised learning could overlook important biomarkers, which mildly correlate with phenotype labels but have strong relevance with disease status.
To address such drawbacks of conventional approaches and fully utilize available biological knowledge, we propose an integrative scheme utilizing protein-protein sub-network and functional gene set information to construct biologically interpretable features for classification purpose. The work of the proposed scheme is shown in Fig. 1 . Specifically, we applied affinity propagation clustering (APC) [8] to a subnetwork identification tool, incorporating both topological adjacency and expression similarity into the calculation of distance between genes. By doing so, we build the subnetworks comprising genes with consistent activities in the local regions of PPI network. Our scheme was applied to the diagnose muscular dystrophy (MD) dataset with six different MD sub-types. Sub-networks built by our scheme captured multiple important pathways related to MD, which other approach could not. Besides physical interaction information from PPI, we also use functional gene set knowledge to build features as functional interactions among genes also play important roles in cellular system. Using both sub-network and functional gene-set derived features, we constructed the classifier to predict the MD sub-types in a biologically interpretable way, i.e, sub-type specificities are reflected in the abnormal activities of differentially expressed subnetworks and functional gene sets. Moreover, the prediction accuracy was substantially improved, especially for some sub-types that are difficult to distinguish. 
II. METHODS

A. Sub-network Construction using APC
1) Protein-Protein Interaction(PPI) information
Proteins collaborate with each other to perform various types of molecular functions and PPI network structure provides their potential interaction information. As the alternations of protein interactions could contribute to diseases, a better understanding of disrupted protein subnetworks is essential for the study of disease systems and biomarker discovery. However, there are some limitations in PPI information: First, current PPI measurements are quite noisy and every existing technique has its own limitations [9] . Second, PPI only provides static information and cannot reflect the dynamics of cellular system. Therefore, the incorporation of other data types such as gene expression is necessary to identify condition-specific sub-networks.
Current computational approaches using PPI information can be categorized into three types: The first type is to identify protein complexes, by extracting densely connected modules [6] ; the second type is to reveal condition specific gene modules utilizing both phenotype label information and expression data [4, 5] ; the third type is to define gene modules through unsupervised clustering approach [10] . Supervised learning is the common practice to discover the biomarkers that differentiate phenotypes. However, such approach is more focused on the disease outcomes, and may overlook the disease mechanisms. As shown in Fig. 2 , serious human diseases such as cancers are usually caused by genetic and environmental factors, through multiple intertwined biological functions. If we focus only on clinical outcome differences, we may lose the important information about coherence of gene activities and their functional roles, which could potentially shed light on the causes, prevention and treatments of diseases. For example, in tumor progression, metabolic activities are the most differentiable signals associated with clinical outcome but provide little information for the understanding of disease. Another example can be found in our MD study, where the muscle degeneration activity can be used for diagnostic purpose but help little for finding treatments. Aiming to keep mildly differentiable but biologically informative sub-network biomarkers, we propose to construct sub-networks without using clinical label information directly, and will describe the details in following sections. Later, we will use classification to highlight MD sub-type specific subnetworks.
2) APC (Affinity Propagation Clustering)
Before we describe the sub-network construction using APC, we will briefly explain APC algorithm in this section. Given a set of data points 
The second term in the function (1) represents a consistency constraint such that if i p is an exemplar for other data points it has to be its own exemplar [8] . 
Once the algorithm is converged, the index of most appropriate exemplar for i p is determined by the following formula:
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The message passing algorithm of APC involves pairwise distance calculations, which can incur serious computational complexity if the number of data points N is large, thus hinder its application. That can explain why APC has been used for microarray sample grouping [11] but not for gene clustering. But with PPI data, since the interactions between proteins are sparse even when the indirectly connected interactions are considered, the computation load of APC will be greatly reduced.
In APC, every data point within one cluster can be "represented" by a common exemplar, which is also a data point. Such exemplar-member relationship resembles the gene module network, where a hub gene interacts with other genes within the same module. The hub gene can be a key regulator affecting or coordinating the activities of other genes. Such resemblance motivates us to devise APC to reveal gene modules by incorporating PPI into the gene-gene relevance calculations. 
Here, If we only focus on the similarity of expression vectors regardless of up or down regulation of the genes, we can measure the relevance S(i, j) between the two genes i and j using the following formula:
Here, d can be any topological distance metric defined based on PPI network structure [12] , and γ is the weight. In this paper, we adopted shortest distance to calculate d and set γ =1. If one wishes to tell up-from down-regulated genes, the relevance in (8) can be modified as following:
In both (8) and (9), the relevance is bounded between 0 and 1, with 1 indicating the highest relevance and 0 the lowest.
3) Significance analysis of generated sub-network
Unlike conventional clustering methods, sub-networks learned by the proposed scheme can be statistically evaluated using significance analysis. Without label information, it is infeasible to design significance analysis for traditional clustering, and the confidence of resulting clusters cannot be statistically evaluated. In contrast, our proposed scheme is semi-supervised by PPI information, therefore we can shuffle the PPI and gene corresponding relationship to assess the reliability of generated sub-networks.
Let's define some statistics to measure the compactness of one sub-network as following:
Here, e is the exemplar gene index, M is the number of genes within the sub-network, and S(i,e) measures the relevance between i-th gene and its hub (or, "exemplar" 
B. Feature constructions and classificaiton
For each identified sub-network, the network activity is defined as the average standardized expression level of its gene members. These sub-network activities will be calculated for each individual microarray sample and treated as the classification features.
Further, we collected 639 functional gene sets from the Molecular Signatures Database (MSigDB) (http://www.broadinstitute.org/gsea/msigdb/) to take the functional interactions between genes into account. For each gene set, we mapped gene symbols to probe set ids, and selected the sub-set of probe sets that have relatively large expression variation across all microarray samples. We define the activity of each new gene set by taking the average of the standardized expressions of all genes belong to the same set, just like we calculated the activity scores for our sub-networks. Then, we define the activity of each gene set using the same technique we used to define the subnetwork activities
For our study, we adopted t-test to rank differentially expressed sub-networks/gene sets, and measured the predicting power of the selected features based on the classification results generated by multiclass support vector machine (MSVM). For comparison purpose, we also analyzed the K-nearest-neighbor (KNN) classifying results. Leave one out cross validation (LOOCV) technique was used for prediction performance evaluation.
III. EXPERIMENTS
A. Muscular dystrophy
Before we explain the Muscular Dystrophy (MD) microarray gene expression data used in this study, we will briefly describe the clinical background of MD disease. Muscular Dystrophy refers to a group of more than 30 genetic muscle diseases characterized by progressive skeletal muscle weakness, defects in muscle proteins, and the death of muscle cells and tissue. The onset of some MD types is in infancy or childhood, while others in middle age or later. The disorders differ in terms of the distribution and extent of muscle weakness, rate of progression, and pattern of inheritance. Among all, Duchenne Muscular Dystrophy (DMD) is known as the most common and fatal form primarily affecting boys, while myotonic MD is the most common form affecting adults. Becker MD (BMD) is similar to DMD but the symptom is less severe. There are no known cure and no specific treatment for any form of MD, and the goal of MD study is focusing on thorough understanding of MD and the development of techniques to diagnose, treat, prevent, and ultimately cure the disorder. In this paper, we will focus on computational analysis for six MD sub-types consisting DMD, BMD, DYS, FKRP, TITIN, and ALS. Total number of samples 68
B. Dataset description
We analyze a microarray dataset acquired by Children's National Medical Center (CNMC). The data consists of 68 microarray samples based on Affymetrix U133-plus2 platform. The disease group consisted of 62 samples of six MD sub-types, and the control group consisted of six 'normal' samples. A brief summary of the dataset is given in Table I . PPI information is collected from the Human Protein Reference Database (HPRD) [13] containing manually curated physical interactions among proteins.
C. Differentially expressed sub-networks and gene sets
Applying our proposed scheme on the MD data, we constructed 122 sub-networks. For comparison purpose, we applied the software implementation of Chuang's algorithm PinnacleZ(http://chianti.ucsd.edu/~slotia/pinnaclez/help.htm) on the same data which uses a phenotype label guided approach to construct the sub-networks. It only built 34 subnetworks which is 28% of the 122 sub-networks built by our approach. In addition, the sizes of the individual subnetworks constructed by our approach are larger than those constructed by PinnacleZ method. 41 (34%) APC identified sub-networks have six to ten genes and 46 (37%) have eleven or more. But 79% of PinnacleZ based sub-networks have six to ten genes, and none has more than ten genes. The summary of comparison is given in TABLE II. More importantly, APC identified sub-networks reveal more biological relevance to MD diseases by capturing eight MD related pathways, while PinnacleZ identified subnetworks captured only three pathways with relatively lower statistical significance. Particularly, three most statistically significant pathways captured by APC namely Cell adhesion molecules, ECE-receptor interaction, and Hematopoietic cell lineage are not included in PinnacleZ identified subnetworks. Table III demonstrates the KEGG pathway term, the number of genes, and the p-value for each MD related pathway captured by APC identified sub-networks (A), and PinnacleZ identified sub-networks (B). Table IV demonstrates biological process enrichment analysis results for the APC identified sub-networks (A) and the PinnacleZ identified sub-networks (B). 
Enriched Biological Processes for APC identified Sub-networks
After performing expression variance based gene filtering, we constructed 558 gene set features out of the 639 functional gene sets from MSigDB.
D. Prediction performance
As summarized in Table V , the prediction accuracy of MSVM based on selected sub-network features is 68%. It is striking to observe a huge contrast between the 100% accuracy for DMD and the 1% accuracy for TITIN. Such a large difference could be explained by several reasons including: i) Clinically, DMD is the most rapidly-worsening MD sub-type accompanied by highly varied expression profiling, and thus serves as the easiest diagnostic case. ii) The number of DMD samples is much larger than that of TITIN, and consequently the training of classifier is biased towards DMD. iii) PPI sub-network based prediction only incorporates physical interaction information, and it may not be sufficient to describe the sub-type differences by using PPI alone.
As functional interaction could also play vital roles in the onset and the progression of MD disease, we further added functional gene set features into our prediction analysis. Surprisingly, the results show the accuracy for TITIN was dramatically improved from 1% to 42%, and the accuracies for DYS, and FKRP were also improved by 30% or more. Fig. 4 demonstrates the prediction performances based on selected sub-network features, and selected combined features (sub-network and gene set). Notice that the prediction accuracy of MSVM classification results based on selected sub-network features is only 72% at best, while the accuracy based on combined features is mostly higher than 72% and increases fast up to 90%. For comparison purpose, we also performed the K-nearest neighbor (KNN) for classification, and displayed the accuracy curves in Fig. 4 . We can see clearly that the MSVM classifier outperforms KNN classifier.
The fact that prediction accuracy is dramatically improved by adding gene set features may suggest that the functional interactions play essential roles in some of the MD sub-types, such as DYS, FKRP and TITIN. Due to the space limit, however, we will not discuss the detailed biological interpretations of the gene sets selected by classifiers. CTRL  52%  76%  24%  BMD  68%  90%  22%  DMD  100%  99%  -1%  DYS  61%  91%  30%  FKRP  35%  70%  35%  TITIN  1%  42%  41%  ALS  86%  97%  11%  Average  68%  86%  18% IV. DISCUSSIONS & CONCLUSIONS Individual gene based machine learning approaches usually unable to reveal the full picture of complex cellular system, and genetic data analysis needs to be accomplished within biological context to fully understand disease mechanism. Recently, researchers struggle to integrate various types of biological knowledge, including literature text-mining results, interaction measurement, functional gene categorization and etc. In our approach, we incorporated both physical and functional interaction knowledge to diagnose different muscular dystrophy sub-types. From prediction results we showed the accuracy improvement by combining features constructed from both knowledge sources. Moreover, we highlighted potential sub-network/gene-set biomarkers through feature selection and classification procedures.
Clinically, DMD is the most severe MD subtype characterized by rapid progression of muscle degeneration [1] , and its expression profiles highly vary. Therefore, it is relatively easy to differentiate DMD from other sub-types. However, it makes difficult to classify some less severe subtypes with lower expression variations, such as TITIN and FKRP. In addition, since all MD sub-types share the common biological processes such as immune response, apoptosis and cell cycle caused by muscle loss, it is even harder to identify sub-type specific biomarkers. Due to those reasons, supervised approach can be biased by dominant expression signals from DMD samples, and fails to capture the gene expression signatures of other weakly distinguishable MD sub-types. In an effort to address such problem, we proposed semi-supervised approach, which builds more biologically interpretable features than conventional clinical label guided approaches [5] . As discovery of new MD biomarkers could contribute to reveal disruption of genetic pathways in MD diseases [14] , our identified sub-network and gene set features may also imply disrupted interactions in related sub-types and provide clues for biological study. As an extension of proposed computational analysis, we will continue to carry out comparative study on normal muscle recovery experiments [15] for a better understanding of the failed muscle regeneration processes in MD.
In our future research, other biological knowledge such as Protein-DNA interaction network structure would also be incorporated into computational analysis for a deeper understanding of MD diseases. However, we should realize the fact that biological knowledge contain errors and noises, because they are collected from different sources, such as biological experiments, automatic text-mining results and manually curated annotations. Therefore, it is important to carefully check the reliability/specificity of biological knowledge [15] and evaluate the impacts on computational analysis. Moreover, the incompleteness of existing biological knowledge makes it difficult to discover the essential biomarkers without further knowledge support, hence computational approaches that utilize but not restricted by biological knowledge are more desirable [16] .
